These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36878916)

  • 1. CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularization.
    Park J; Cui G; Lee H; Jeong H; Kwak JJ; Lee J; Byeon SH
    Sci Rep; 2023 Mar; 13(1):3715. PubMed ID: 36878916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration.
    Koo T; Park SW; Jo DH; Kim D; Kim JH; Cho HY; Kim J; Kim JH; Kim JS
    Nat Commun; 2018 May; 9(1):1855. PubMed ID: 29748595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Hypoxia-Regulated Retinal Pigment Epithelium-Specific Gene Therapy Vector Reduces Choroidal Neovascularization in a Mouse Model.
    Yuan Y; Kong W; Liu XM; Shi GH
    Curr Gene Ther; 2022; 22(5):417-426. PubMed ID: 35382718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice.
    Ling S; Yang S; Hu X; Yin D; Dai Y; Qian X; Wang D; Pan X; Hong J; Sun X; Yang H; Paludan SR; Cai Y
    Nat Biomed Eng; 2021 Feb; 5(2):144-156. PubMed ID: 33398131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
    Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
    J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.
    Schnabolk G; Coughlin B; Joseph K; Kunchithapautham K; Bandyopadhyay M; O'Quinn EC; Nowling T; Rohrer B
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1850-63. PubMed ID: 25593023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization.
    Oshima Y; Oshima S; Nambu H; Kachi S; Hackett SF; Melia M; Kaleko M; Connelly S; Esumi N; Zack DJ; Campochiaro PA
    J Cell Physiol; 2004 Dec; 201(3):393-400. PubMed ID: 15389527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.
    Biswal MR; Prentice HM; Smith GW; Zhu P; Tong Y; Dorey CK; Lewin AS; Blanks JC
    J Mol Med (Berl); 2018 Oct; 96(10):1107-1118. PubMed ID: 30105447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni.
    Kim E; Koo T; Park SW; Kim D; Kim K; Cho HY; Song DW; Lee KJ; Jung MH; Kim S; Kim JH; Kim JH; Kim JS
    Nat Commun; 2017 Feb; 8():14500. PubMed ID: 28220790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Choroidal Neovascularization in Mice by Subretinal Delivery of Multigenic Lentiviral Vectors Encoding Anti-Angiogenic MicroRNAs.
    Askou AL; Benckendorff JNE; Holmgaard A; Storm T; Aagaard L; Bek T; Mikkelsen JG; Corydon TJ
    Hum Gene Ther Methods; 2017 Aug; 28(4):222-233. PubMed ID: 28817343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascularization in a laser-induced mouse model.
    Zhang ZX; Wang YS; Shi YY; Hou HY; Zhang C; Cai Y; Dou GR; Yao LB; Li FY
    Curr Eye Res; 2011 Sep; 36(9):838-49. PubMed ID: 21851170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Inhibition of Choroidal Neovascularization by scAAV2 with VMD2 Promoter-driven Active Rap1a in the RPE.
    Wang H; Kunz E; Stoddard GJ; Hauswirth WW; Hartnett ME
    Sci Rep; 2019 Oct; 9(1):15732. PubMed ID: 31673119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.
    Ablonczy Z; Dahrouj M; Marneros AG
    FASEB J; 2014 May; 28(5):2369-79. PubMed ID: 24558195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subretinal transplantation of retinal pigment epithelium overexpressing fibulin-5 inhibits laser-induced choroidal neovascularization in rats.
    Li F; Zeng Y; Xu H; Yin ZQ
    Exp Eye Res; 2015 Jul; 136():78-85. PubMed ID: 25983185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy.
    Askou AL; Alsing S; Benckendorff JNE; Holmgaard A; Mikkelsen JG; Aagaard L; Bek T; Corydon TJ
    Mol Ther Nucleic Acids; 2019 Jun; 16():38-50. PubMed ID: 30825671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Evaluation of Retinal Morphology and Function in Rosa26-Cas9 Knock-In Mice.
    Mohan K; Dubey SK; Jung K; Dubey R; Wang QJ; Prajapati S; Roney J; Abney J; Kleinman ME
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Disruption of VEGF-A Expression in Human Retinal Pigment Epithelial Cells Using CRISPR-Cas9 Endonuclease.
    Yiu G; Tieu E; Nguyen AT; Wong B; Smit-McBride Z
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5490-5497. PubMed ID: 27768202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.
    Kim K; Park SW; Kim JH; Lee SH; Kim D; Koo T; Kim KE; Kim JH; Kim JS
    Genome Res; 2017 Mar; 27(3):419-426. PubMed ID: 28209587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.